Depression drug may relieve pain from breast cancer treatment
December 13th, 2010 - 1:17 pm ICT by ANIWashington, Dec 13 (ANI): A new study has found that a drug usually used to treat depression and anxiety disorder helped in reducing joint and muscle pain linked with a breast cancer treatment.
The women in the University of Michigan study were taking aromatase inhibitors, a type of drug designed to block the production of estrogen, which fuels some breast cancers.
“Since women typically take these drugs for five years, it is important that the side effects not interfere too much with their quality of life, or they will be less likely to continue taking the medicine, which may lead to a greater chance of their breast cancer returning,” said study author N. Lynn Henry.
The study looked at the drug duloxetine, or Cymbalta, which is used to treat depression and generalized anxiety disorder.
It’s also been shown to work in multiple other chronic pain conditions, such as fibromyalgia and, more recently, osteoarthritis.
The study found that out of 29 patients evaluated, nearly three-quarters witnessed decrease in pain by at least by 30 percent.
On average, after eight weeks of treatment, pain scores declined 61 percent. Only one in five patients stopped taking duloxetine because of side effects.
“Duloxetine appears to be effective at reducing the muscle and joint pain many women experience from aromatase inhibitors, with only mild additional side effects,” said Henry.
The findings were presented at the 33rd Annual San Antonio Breast Cancer Symposium. (ANI)
- Depression drug may ease pain from breast cancer treatment: Study - Dec 12, 2010
- Anti-depressants ease osteoarthritis pain - Mar 23, 2012
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Acupuncture could relieve joint pain linked to breast cancer treatments - Mar 05, 2010
- How breast cancer drug causes arthritis in some women - Sep 28, 2010
- Music therapy ease pain in muscles, joints - May 27, 2011
- Exercise can cut risk of cancer returning - Aug 08, 2011
- Novel drug eases osteoarthritis knee pain - Sep 30, 2010
- Simple fingertip test may identify breast cancer patients at CTS risk - Dec 11, 2010
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Hair loss medications can affect men's sexual health - Mar 08, 2011
- Mood, anxiety disorders patients likely to abuse painkillers - Dec 14, 2011
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Gene test may bring safe chemotherapy - Mar 23, 2012
- New drug slows oesteoarthritis progression (Lead) - Mar 23, 2012
Tags: antonio breast cancer symposium, aromatase inhibitors, breast cancer, breast cancer symposium, breast cancer treatment, breast cancers, chronic pain conditions, cymbalta, depression drug, duloxetine, five patients, generalized anxiety disorder, lynn henry, michigan study, muscle and joint pain, pain scores, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, three quarters